angioblast


Also found in: Medical, Wikipedia.

angioblast

[′an·jē·ə‚blast]
(embryology)
A mesenchyme cell derived from extraembryonic endoderm that differentiates into embryonic blood cells and endothelium.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Based on the results obtained from the developmental studies, they speculate that new LECs could arise from preexisting lymphatic vessels through the process of lymphangiogenesis or, alternatively, they could originate from angioblast niches maintained within veins, or throughout the body, via lymph vasculogenesis.
The former vasculogenesis is the formation of new blood vessels from bone marrow derived angioblast, while the latter is formation of new blood vessels from already present vascular structures.
Meanwhile, the increase of bleeding allows the angioblast cells to enter the space under periosteum, which is beneficial to the vascularization of newly formed bone.
Evidence accumulated in the past two decades indicates that peripheral blood cells contain a subpopulation with properties similar to embryonic angioblast [23-26].
Therapies employing adult stem cells are being developed by various companies (such as ViaCell, StemSource, Osiris Therapeutics, Neural Stem, and Angioblast) and are moving fast from the laboratory to the clinic.
- Acquired 100% of Angioblast and entire intellectual property for MPCs
12 May 2010 - Australian biotechnology company Mesoblast Limited (ASX: MSB) said today it plans to purchase the 67% stake it does not already own in US sector player Angioblast Systems Inc in a bid to expand its portfolio.
Articles then review strategies for cell delivery, clinical trials, therapies such as whole bone marrow transplantation, clinical angioblast therapy and the use of skeletal myoblasts and other techniques, and the future of the field.
The trials are being conducted in conjunction with Mesoblast U.S.-based sister company, Angioblast Systems Inc.
The term "haemangioblast" was coined by Murray [4] and is different from "angioblast," as initially suggested by Sabin [10].
Melbourne, Australia, Dec 23, 2010 - (ABN Newswire) - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it had completed its acquisition of United States company Angioblast Systems Inc with the issue of 90.8 million ordinary shares to former Angioblast security holders, increasing the total number of shares on offer to 253.8 million shares.